Basal Cell Carcinoma Therapeutics Market Report

China Basal Cell Carcinoma Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 28, 2023
  • PAGES：152
  • REPORT CODE：GMM1817151
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Basal Cell Carcinoma (BCC) is a form of non-melanocytic skin cancer that arises from basal cells, the small, round cells present in the lower epidermis. Around 85% of BCCs occur on the face, head and neck. BCCs usually do not spread or metastasize to other parts of body, they become life threatening by metastasis only in extremely rare cases. According to the American Cancer Society, BCCs constitute around 80% of all non-melanoma skin cancers. Australia has been found to have the highest rate of basal cell carcinoma across the globe. Exposure to ultraviolet radiation is considered as the major cause behind BCC. Use of immunosuppressant drugs further enhance the chances of BCC as the immune system is compromised. White people are more vulnerable to BCC comparatively, according to a research published in the British Medical Journal. The symptoms of BCCs include waxy papules (slightly transparent bump) with pearly appearance and central depression and bleeding from the papules.

    The increase in geriatric population, giving rise to numerous skin diseases, such as actinic keratosis and other non-melanoma skin malignancies, is another important factor that has been fueling the demand for basal cell carcinoma treatment substantially. In addition to these, the market is expected to gain considerably from the changing lifestyle of people in developing economies over the coming years as it is anticipated to drive demand for better disease treatments, which in turn, is likely to provide lucrative opportunities for the companies operating in the global basal cell carcinoma treatment market. North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa are considered as the prominent geographical segments of this market. North America, which is the current market leader, is expected to remain dominant over the next few years. The presence of a well-established medical and healthcare infrastructure, increasing expenditure on healthcare, and the high prevalence of basal cell carcinoma in this region are likely to boost the growth of the market for basal cell carcinoma treatment in North America.

    This report elaborates on the current development of the Basal Cell Carcinoma Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • F Hoffmann-Lа Rосhе

    • Меrсk

    • Муlаn

    • Valeant Pharmaceuticals International

    By Type:

    • Drug

    • Photodynamic Therapy

    • Surgery

    • Radiation Therapy

    By Application:

    • Retail Pharmacy

    • Cancer Research Institute

    • Hospital Pharmacy

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Basal Cell Carcinoma Therapeutics Market Overview 2018-2029

    • 1.1 China Basal Cell Carcinoma Therapeutics Industry Development Overview

    • 1.2 China Basal Cell Carcinoma Therapeutics Industry Development History

    • 1.3 China Basal Cell Carcinoma Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Basal Cell Carcinoma Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Drug (2018-2029)

      • 1.4.2 China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Photodynamic Therapy (2018-2029)

      • 1.4.3 China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

      • 1.4.4 China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Radiation Therapy (2018-2029)

    • 1.5 China Basal Cell Carcinoma Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Basal Cell Carcinoma Therapeutics Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)

      • 1.5.2 China Basal Cell Carcinoma Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer Research Institute (2018-2029)

      • 1.5.3 China Basal Cell Carcinoma Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)

    • 1.6 China Basal Cell Carcinoma Therapeutics Market Analysis by Region

      • 1.6.1 North China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Basal Cell Carcinoma Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Basal Cell Carcinoma Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Basal Cell Carcinoma Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Basal Cell Carcinoma Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Basal Cell Carcinoma Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Basal Cell Carcinoma Therapeutics Industry Development

    Chapter 3 Basal Cell Carcinoma TherapeuticsIndustry Chain Analysis

    • 3.1 Basal Cell Carcinoma Therapeutics Industry Chain

    • 3.2 Basal Cell Carcinoma Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Basal Cell Carcinoma Therapeutics Market

    • 3.3 Basal Cell Carcinoma Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Basal Cell Carcinoma Therapeutics Market

    Chapter 4 China Basal Cell Carcinoma Therapeutics Market, by Type

    • 4.1 China Basal Cell Carcinoma Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Basal Cell Carcinoma Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Drug

      • 4.5.2 China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Photodynamic Therapy

      • 4.5.3 China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Surgery

      • 4.5.4 China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Radiation Therapy

    Chapter 5 China Basal Cell Carcinoma Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Basal Cell Carcinoma Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate of Retail Pharmacy

      • 5.5.2 China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate of Cancer Research Institute

      • 5.5.3 China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate of Hospital Pharmacy

    Chapter 6 China Basal Cell Carcinoma Therapeutics Market, by Region

    • 6.1 China Basal Cell Carcinoma Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Basal Cell Carcinoma Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Basal Cell Carcinoma Therapeutics Market Analysis

    • 7.1 North China Basal Cell Carcinoma Therapeutics Market, by Type

    • 7.2 North China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 8 Central China Basal Cell Carcinoma Therapeutics Market Analysis

    • 8.1 Central China Basal Cell Carcinoma Therapeutics Market, by Type

    • 8.2 Central China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 9 South China Basal Cell Carcinoma Therapeutics Market Analysis

    • 9.1 South China Basal Cell Carcinoma Therapeutics Market, by Type

    • 9.2 South China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 10 East China Basal Cell Carcinoma Therapeutics Market Analysis

    • 10.1 East China Basal Cell Carcinoma Therapeutics Market, by Type

    • 10.2 East China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 11 Northeast China Basal Cell Carcinoma Therapeutics Market Analysis

    • 11.1 Northeast China Basal Cell Carcinoma Therapeutics Market, by Type

    • 11.2 Northeast China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 12 Southwest China Basal Cell Carcinoma Therapeutics Market Analysis

    • 12.1 Southwest China Basal Cell Carcinoma Therapeutics Market, by Type

    • 12.2 Southwest China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 13 Northwest China Basal Cell Carcinoma Therapeutics Market Analysis

    • 13.1 Northwest China Basal Cell Carcinoma Therapeutics Market, by Type

    • 13.2 Northwest China Basal Cell Carcinoma Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 F Hoffmann-Lа Rосhе

        • 14.1.1 F Hoffmann-Lа Rосhе Company Profile

        • 14.1.2 F Hoffmann-Lа Rосhе Basal Cell Carcinoma Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Меrсk

        • 14.2.1 Меrсk Company Profile

        • 14.2.2 Меrсk Basal Cell Carcinoma Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Муlаn

        • 14.3.1 Муlаn Company Profile

        • 14.3.2 Муlаn Basal Cell Carcinoma Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Valeant Pharmaceuticals International

        • 14.4.1 Valeant Pharmaceuticals International Company Profile

        • 14.4.2 Valeant Pharmaceuticals International Basal Cell Carcinoma Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Basal Cell Carcinoma Therapeutics Industry Research Conclusions

    • 15.2 Basal Cell Carcinoma Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Basal Cell Carcinoma Therapeutics Industry Market Size (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Drug (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Photodynamic Therapy (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Surgery (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume, Production Value and Growth Rate of Radiation Therapy (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Sales Volume, Sales Value and Growth Rate of Retail Pharmacy (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Sales Volume, Sales Value and Growth Rate of Cancer Research Institute (2018-2029)

    • Figure China Basal Cell Carcinoma Therapeutics Sales Volume, Sales Value and Growth Rate of Hospital Pharmacy (2018-2029)

    • Figure North China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Basal Cell Carcinoma Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Basal Cell Carcinoma Therapeutics Market Share by Type in 2018

    • Figure China Basal Cell Carcinoma Therapeutics Market Share by Type in 2023

    • Figure China Basal Cell Carcinoma Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Drug (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Photodynamic Therapy (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Surgery (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume and Growth Rate of Radiation Therapy (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Market Share by Application in 2018

    • Figure China Basal Cell Carcinoma Therapeutics Market Share by Application in 2023

    • Figure China Basal Cell Carcinoma Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate of Retail Pharmacy (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate of Cancer Research Institute (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Market Size and Growth Rate of Hospital Pharmacy (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Production Volume by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Production Value by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Production Value Share by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Sales Volume by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Sales Value by Region (2018-2023)

    • Table China Basal Cell Carcinoma Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Basal Cell Carcinoma Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table North China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table South China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table East China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Basal Cell Carcinoma Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Basal Cell Carcinoma Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Basal Cell Carcinoma Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Basal Cell Carcinoma Therapeutics Sales Volume Share by Application (2018-2023)

    • Table F Hoffmann-Lа Rосhе Company Profile

    • Table F Hoffmann-Lа Rосhе Basal Cell Carcinoma Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Меrсk Company Profile

    • Table Меrсk Basal Cell Carcinoma Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Муlаn Company Profile

    • Table Муlаn Basal Cell Carcinoma Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Valeant Pharmaceuticals International Company Profile

    • Table Valeant Pharmaceuticals International Basal Cell Carcinoma Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US